Table 1 Distribution by diabetes-related diagnostic groups of participants in Lolland-Falster Health Study aged 20 + years: Determinants, 2016–2019
Diagnostic group | Men | Women | Total | |||
|---|---|---|---|---|---|---|
n | % with (95% CI) | n | % with (95% CI) | n | % with (95% CI) | |
No DM | 4182 | 79 (78.0–80.1) | 4722 | 84.3 (83.4–85.2) | 8904 | 81.7 (81.0–82.4) |
Prediabetes | 325 | 6.1 (5.1–7.2) | 308 | 5.5 (4.6–6.4) | 633 | 5.8 (5.1–6.5) |
Undiagnosed DM | 55 | 1.0 (0–2.1) | 27 | 0.5 (0–1.4) | 82 | 0.8 (0.1–1.4) |
Poorly controlled DM | 81 | 1.5 (0.5–2.6) | 47 | 0.8 (0–1.7) | 128 | 1.2 (0.5–1.9) |
Potentially sub-controlled DM | 148 | 2.8 (1.8–3.9) | 75 | 1.3 (0.4–2.2) | 223 | 2.0 (1.4–2.7) |
Well-controlled DM | 138 | 2.6 (1.6–3.7) | 90 | 1.6 (0.7–2.5) | 228 | 2.1 (1.4–2.8) |
Missing/ unclassified | 362 | 6.8 (5.8–7.9) | 335 | 6.0 (5.1–6.9) | 697 | 6.4 (5.7–7.1) |
Total with missing/ unclassified | 5291 | 100 | 5604 | 100 | 10,895 | 100 |
Total excluding missing/ unclassified | 4929 | 93.2 | 5269 | 94.0 | 10,198 | 93.6 |
DMRC | 609 | 11.5 (10.7–12.4) | 457 | 8.2 (7.5–8.9) | 1066 | 9.8 (9.2–10.4) |
DM diagnosed | 367 | 100 | 212 | 100 | 579 | 100 |
- HbA1c ≥ 53 mmol/mol | 160 | 43.6 (38.4–48.9) | 88 | 41.5 (34.9–48.4) | 248 | 42.8 (38.7–47.0) |
- HbA1c < 53 mmol/mol | 207 | 56.4 (51.2–61.7) | 124 | 58.5 (51.9–65.4) | 331 | 57.2 (53.0–61.4) |